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Objectives. This study sought to evaluate expression of adhe-
sion molecules on neutrophils and monocytes throughout the
acute phase of myocardial infarction.
Background. Neutrophil and monocyte counts increase within
days from onset of acute myocardial infarction. Because leuko-
cytes are recruited to the involved myocardial region, we postu-
lated that these activated cells would display an increased expres-
sion of adhesion molecules necessary for effective endothelial
transmigration.
Methods. We measured the expression of neutrophil and mono-
cyte lymphocyte function associated antigen-1 (LFA-1), Mac-1,
very late after activation antigen-4 (VLA-4) and intercellular
adhesion molecule-1 (ICAM-1) by flow cytometry throughout the
acute phase of acute myocardial infarction in 25 patients and 10
age-matched control subjects.
Results. Expression of Mac-1 on neutrophils increased signifi-
cantly, whereas no expression of VLA-4 and ICAM-1 was detected.
The expression of LFA-1, Mac-1, VLA-4 and ICAM-1 on the
monocyte cell membrane in patients with an acute myocardial
infarction was increased compared with that in control subjects by
22% (on day 7), 67%, 13% and 44% (all on day 4), respectively (all
p < 0.001). Elevated density of monocyte-specific CD14 in the
AMI versus the control group was also shown (30%, p < 0.001).
Conclusions. Increased expression of neutrophil and monocyte
adhesion molecules may contribute to their adhesion to endothe-
lium in the ischemic territory. This adhesion could feasibly
precipitate vasoconstriction or add a local thrombotic effect due to
tissue factor expression secondary to Mac-1 engagement. In
addition, the manifestation of increased density of LFA-1 and
Mac-1 by activated leukocytes with monocytes also expressing
ICAM-1 suggests that leukocytes may form microaggregates that
could cause microvascular plugging. This mechanism may facili-
tate the occurrence of the “no-reflow” phenomenon or slow
coronary filling after acute myocardial infarction.
(J Am Coll Cardiol 1998;31:120–5)
©1998 by the American College of Cardiology
Infiltration of necrotic myocardial tissue by neutrophils within
the first day and by monocytes beyond the third day of onset of
acute myocardial infarction has long been documented by
histopathologic examination (1,2). Increased neutrophil count
is known to occur very commonly within the first day from
onset of myocardial infarction (3). We have previously docu-
mented (Meisel SR, et al., in preparation), and more recently
Tashiro et al. (4) have reported, an increase in monocyte count
2 to 3 days after myocardial infarction. Because these increases
occur at the time that neutrophils and monocytes begin to
accumulate in the involved myocardium, we hypothesized that
this phenomenon represents peripheral recruitment of leuko-
cytes to necrotic cardiac muscle. The monocytes play a major
part in the necessary debridement of necrotic tissue through
their scavenger function and thus set the stage for the healing
process (1,2). The role of the neutrophils, in contrast, is less
clear. However, the presence of leukocytes in the myocardium
requires endothelial transmigration, which is facilitated by the
expression of adhesion molecules by leukocytes and endothe-
lial cells alike (5). We surmised, therefore, that the increase in
neutrophil and monocyte counts during myocardial infarction
would be accompanied by a corresponding increase in their
expression of cell-surface adhesion molecules to enhance
endothelial transmigration required for tissue infiltration.
Upregulation of neutrophil and monocyte adhesion mole-
cules is clinically relevant because activated leukocytes could
adhere to altered coronary endothelium downstream to the
culprit lesion and modify local vasomotor function (6). Fur-
thermore, this adherence could lead to the enhancement of
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monocyte tissue factor expression due to engagement of Mac-1
receptor (7), thus adding a local thrombotic procoagulant
effect as well. This mechanism may explain the occasional
occurrence of the “no-reflow” phenomenon in the acute stage
of myocardial infarction or persistent ischemia despite recan-
alization of the occluded infarct-related artery.
The goal of the present study, therefore, was to evaluate the
changes in the expression of neutrophil and monocyte
membrane-associated adhesion molecules throughout the
acute phase of myocardial infarction.
Methods
Subjects. The study included 25 patients (18 men, 7 wom-
en; mean [6SD] age 59 6 14 years), 9 with an anterior
myocardial infarction, and 16 with an acute myocardial infarc-
tion in other anatomic locations (inferior or inferoposterior).
Nineteen patients (76%) received thrombolytic therapy, and
no patient had a clinical course complicated by cardiogenic
shock or significant congestive heart failure. Patients, recruited
from June 1994 to March 1995, were consecutively included if
they fulfilled the following criteria: 1) onset of severe symp-
toms ,3 h before admission, to exclude patients with myocar-
dial reinfarction or a “stuttering” pattern; 2) admission was
between 7 AM and 3 PM to ensure prompt analysis of samples.
Ten normal subjects, matched for age and gender (mean age
54 6 9 years; seven men, three women), without any known
underlying disease and taking no medication were selected as
a control group. Acute myocardial infarction was defined by at
least two of the three following major criteria: clinical presen-
tation; typical and unequivocal electrocardiographic changes;
and significant cardiac enzyme elevation (more than three
times the upper limit of the normal range).
Adhesion molecules. The expression of the following adhe-
sion molecules on neutrophils and monocytes was measured
using flow cytometry: 1) CD11a, which is the alpha-chain of the
heterodimer CD11a/CD18, also termed lymphocyte function
associated antigen-1 (LFA-1). 2) CD11b, which is the alpha-
chain of the heterodimer CD11b/CD18, also termed Mac-1. 3)
CD29d, which is the alpha-chain of the heterodimer CD29d/
CD49, also termed very late after activation antigen-4 (VLA-4).
4) CD54, termed intercellular adhesion molecule-1 (ICAM-1).
Another membrane molecule measured was CD14, which is
the receptor that binds the complex lipopolysaccharide–
lipopolysaccharide binding protein. CD14 is expressed on
.90% to 95% of monocytes (5); therefore, it is considered a
specific monocyte marker and enables the assessment of the
quality of monocyte gating.
Sodium EDTA-anticoagulated blood specimens for com-
plete blood count with a differential count were drawn in
patients on admission and daily during their stay in the
coronary care unit. Samples were analyzed by a Technicon H-1
System (Miles) and enabled the evaluation of neutrophil and
monocyte kinetics during the several days after onset of
myocardial infarction.
Flow cytometric quantification of the specified adhesion
molecules was performed in patients on admission (day 1), 3
days later (day 4) and 6 days later (day 7). Blood samples for
the same tests were drawn in the control group three times
according to the previously described schedule.
Flow cytometry. The technique of flow cytometry involves
the staining of blood cells with fluorescence-tagged antibodies
targeted to specific cell surface-associated antigens. This is
followed by quantification of fluorescence intensity in the cell
population of interest as a measure of the specific antigen
abundance and by determination of the percentage of cells
displaying fluorescence intensity beyond a threshold. Samples
were processed by a Coulter Q Prep work station (Coulter
Immunology) according to the manufacturer’s specifications.
Briefly, 100 ml of whole blood was mixed with 10 ml of
monoclonal antibody and incubated at room temperature for
10 min. The sample was then processed with a 35-s cycle by the
Coulter Q Prep workstation, which sequentially added reagent
A (formic acid) to lyze erythrocytes, reagent B (sodium
carbonate/sodium chloride/sodium sulfate) to stabilize leuko-
cytes and reagent C (paraformaldehyde) as fixative.
Monoclonal antibodies used were either fluorescein isothio-
cyanate or phycoerythrin conjugated and included anti-CD11a,
anti-CD11b (Dako, A/S, Denmark) and anti-CD14, anti-CD29
and anti-CD54 (Immunotech, Luminy, France), with appropri-
ate isotype negative controls.
Analysis by flow cytometry was performed on whole blood
specimens by EPICS PROFILE II Flow Cytometer (Coulter
Ltd., Luton, United Kingdom) equipped with a 15-mW,
488-nm argon ion laser. Red and green fluorescence emissions
were recorded at 580 and 530 nm, respectively. A total of at
least 2,000 events/sample were analyzed.
The neutrophil and monocyte peak was electronically iso-
lated by collection of a dual-parameter histogram of log 90°
light scatter versus forward angle light scatter. Fluorescence
intensity of the measured adhesion molecule was expressed as
mean channel units.
Relative and absolute numbers of cells in each subset were
calculated using the histogram data and the absolute leukocyte
count. Hence, percent gated neutrophils or monocytes, which
represents the fraction of cells expressing the particular cell
surface molecule beyond a certain threshold, was automatically
obtained.
Statistics. Results are expressed as mean value 6 SD.
Multivariate analysis of variance with repeated measures
Abbreviations and Acronyms
CK 5 creatine kinase
GM-CSF 5 granulocyte–monocyte colony stimulating factor
ICAM-1 5 intercellular adhesion molecule-1
IL 5 interleukin
LFA-1 5 lymphocyte function associated antigen-1
TNF 5 tumor necrosis factor
VCAM-1 5 vascular cell adhesion molecule-1
VLA-4 5 very late after activation antigen-4
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(SPSS for the PC) was used to evaluate statistical significance
of differences between groups and day of sampling. Variables
included in the analysis were LFA-1, Mac-1, VLA-4, ICAM-1
and CD14, and these were controlled by the same variables
obtained in the control subjects. Pattern of changes between
sampling days compared with control trend was also evaluated
in the analysis. A resulting p value ,0.05 was deemed to signify
statistical significance.
Results
Patients and control subjects. Patients and control subjects
were matched for age and gender. Seventy-six percent of
patients underwent thrombolytic therapy. Subgroup analysis of
adhesion molecule expression according to the administration
of thrombolytic therapy revealed no difference between pa-
tients who underwent such treatment and those who did not
(data not shown); therefore, postmyocardial infarction patients
were analyzed as one group for the evaluation of changes in
adhesion molecule expression.
The average changes in the expression of the measured cell
surface molecules on neutrophils and monocytes throughout
the hospital period are displayed graphically in Figures 1 to 4.
The expression of Mac-1 in neutrophils was increased in
patients by 133% (p , 0.001) on day 1 compared with that in
age-matched control subjects. No expression of VLA-4 and
ICAM-1 was detected in neutrophils. The results demonstrate
that the expression of the adhesion molecules LFA-1, Mac-1
and VLA-4 on monocytes was increased in patients compared
with that in control subjects throughout the length of the
hospital stay (days 1, 4 and 7) in a statistically significant
manner (p # 0.001). The elevation in LFA-1 and Mac-1 was
already evident at the day of presentation, demonstrating an
early response. ICAM-1, in contrast, increased significantly in
patients compared with control subjects from day 4 onward
(p , 0.001) (Fig. 4). In monocytes, the average maximal
Figure 1. Intensity changes of LFA-1 expression in monocytes (A) and
neutrophils (B) after an acute myocardial infarction. Intensity is
expressed in mean channels. Statistical significance of difference: A,
pgroup 5 0.001 (pgroup represents statistical significance of difference
between groups); pday 5 0.003 (pday represents statistical significance
of difference between groups); interaction 5 0.474 (showing statistical
significance of divergent trend between groups); B, pgroup and pday 5
NS. Solid bars 5 control group; open bars 5 infarction group.
Figure 2. Intensity changes of Mac-1 expression in monocytes (A) and
neutrophils (B) after an acute myocardial infarction. Intensity is
expressed in mean channels. Statistical significance of difference: A,
pgroup , 0.001; pday 5 0.023; interaction 5 0.95; B, pgroup and pday 5
0.001. Abbreviations and symbols as in Figure 1.
Figure 3. Intensity changes of VLA-4 expression in monocytes after an
acute myocardial infarction. Intensity is expressed in mean channels.
Statistical significance of difference: pgroup , 0.001; pday 5 0.01;
interaction 5 0.42. Abbreviations and symbols as in Figure 1.
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change and day of occurrence of LFA-1, Mac-1, VLA-4,
ICAM-1 and CD14 as recorded were 22% on day 7, 67% on
day 4, 13% on day 4, 44% on day 4 and 29% on day 4,
respectively.
CD14, the monocyte-specific cell surface marker, displayed
a pronounced difference between patients and normal control
subjects (p , 0.001) but without a temporal variation through-
out the study period (p # 0.08). This cell surface receptor
responded as a preformed cellular component that reached its
maximal expression very soon after the onset of myocardial
infarction.
No significant changes in percent distribution of gated
neutrophils or monocytes throughout the study period were
recorded with respect to adhesion molecules studied. There-
fore, it can be concluded that only the fluorescence intensity
(corresponding to receptor density) increased, but not the
fraction of leukocytes expressing the adhesion molecules stud-
ied.
The average monocyte counts for the patients were 599 6
268, 772 6 319 and 778 6 309 cells/mm3 for days 1 (on
admission), 2 and 3, respectively. Conversely, the average
monocyte counts for the control group were 459 6 154, 420 6
116 and 474 6 175 cells/mm3 for their three measurements.
The difference between the groups was statistically significant
(p , 0.0025). No statistically significant difference between
monocyte counts obtained on disparate sampling days in both
study groups was demonstrated.
The average creatine kinase (CK) values for postinfarction
patients were 1,133 6 2,031, 2,128 6 2,100 and 906 6 1,200
U/liter for days 1, 2 and 3, respectively (normal range ,190
U/liter); CK values were not obtained for normal subjects.
There was no correlation between CK levels in patients and the
magnitude of change in the expression of any of the adhesion
molecules evaluated.
Discussion
The principal finding in the present study is that circulating
neutrophils in patients with an acute myocardial infarction
express higher densities of the cell surface adhesion molecule
Mac-1 than control subjects, and monocytes display signifi-
cantly more LFA-1, Mac-1, VLA-4 and ICAM-1, as well as the
monocyte-specific marker CD14. In addition, we confirmed
previous reports that after myocardial infarction, there is an
increase in monocyte count (4). The patients were age and
gender matched to the control subjects. Most patients (76%)
were treated with thrombolytic agents, a fact that can be
accounted for by the study design, which enlisted patients with
a short duration of symptoms before admission, but this did
not affect the extent of change in the expression of adhesion
molecules evaluated.
Adhesion molecule interactions. LFA-1 and Mac-1 are
beta2-integrins that promote the adherence of neutrophils and
monocytes to ICAM-1 on the endothelial cell and facilitate
their spread on its surface as the second step in the adhesive
cascade (5,8). LFA-1 is found on all leukocytes, whereas Mac-1
is present in myeloid cells and monocytes. ICAM-1, as well as
vascular cell adhesion molecule-1 (VCAM-1), are members of
the immunoglobulin supergene family, but the former serves as
a ligand for the beta2-integrins, LFA-1 and Mac-1. ICAM-1 is
moderately expressed on endothelial cells and is also localized
on lymphocytes and monocytes (5). Expression of ICAM-1 on
endothelial cells is upregulated by the cytokines interleukin
(IL)-1, tumor necrosis factor-alpha (TNF-alpha) and interferon-
gamma (9,10). Hence, its presence on vascular endothelial cells
enables the adherence of leukocytes and their transmigration
into the tissue.
VLA-4 is a beta1-integrin leukocyte adhesion molecule that
binds to VCAM-1. The latter is an adhesion molecule that
resides on endothelial cell membranes but is mainly expressed
after activation with the cytokines IL-1, IL-6 and TNF-alpha,
which are increased in myocardial infarction and feasibly more
in the vicinity of myocardial necrosis. Monocyte VLA-4 inter-
action with endothelial VCAM-1 induces leukocyte “rolling”
on lumen surface (11) and augments the effect of the beta2-
integrin–ICAM-1 interaction on monocyte endothelium ad-
herence. Hence, the finding of significantly increased expres-
sion of the adhesion molecules LFA-1, Mac-1 and VLA-4 on
monocytes clearly attests to their enhanced tendency to adhere
to activated endothelial cells.
The expression of monocyte ICAM-1 in our study was
significantly increased after myocardial infarction. Despite the
fact that the role of ICAM-1 on the leukocyte membrane has
not been fully elucidated, this may indicate its significance in
mediating leukocyte–leukocyte adhesion as a means of inter-
cellular communication.
Proposed mechanism for monocyte activation. A plausible
mechanism that accounts for leukocyte activation after an
acute myocardial infarction can be based on T cell activation
by cardiac antigens that are normally contained within the
intact myocyte and that are released from necrotic cells after
infarction. Activation of T cells generates cytokines, such as
interferon-gamma, IL-3 and granulocyte–monocyte colony
stimulating factor (GM-CSF). These cytokines cause leukocyte
activation and, subsequently, the secretion from monocytes of
IL-1 and TNF-alpha, which further induces synthesis and
Figure 4. Intensity changes of ICAM-1 expression in monocytes after
an acute myocardial infarction. Intensity is expressed in mean chan-
nels. Statistical significance of difference: pgroup , 0.001; pday 5 0.005;
interaction 5 0.005. Abbreviations and symbols as in Figure 1.
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release of GM-CSF and IL-6 by fibroblasts and endothelial
cells (12), along with augmentation of monocyte activation as
an autocrine effect (13). Indeed, TNF-alpha concentrations
have been reported to be increased in myocardial infarction
(14,15), as well as the levels of IL-1 (16). These lymphocyte-
and monocyte-derived cytokines are probably instrumental not
only in increasing peripheral monocyte count but also in
inducing their activation, as manifested by the elevated cell
surface density of adhesion molecules, in keeping with the
findings of the present study.
Clinical implications. Evidence for changes in the expres-
sion of leukocyte cell surface adhesion molecules is important
and clinically relevant. It may provide the pathogenesis for the
“no-reflow” or “slow-reflow” phenomenon that seems to occur
often in the context of myocardial infarction after reperfusion
by thrombolysis, as described by Gibson et al. (17). This
phenomenon may also account for some postinfarction events,
such as ongoing ischemia and infarction extension. Activated
leukocytes exhibiting increased expression of cell surface ad-
hesion molecules could adhere to altered coronary endothe-
lium downstream to culprit lesion and modify local vasomotor
function (6), thus compromising runoff flow. Ma et al. (18)
showed that ICAM-1–dependent neutrophil adherence plays
an important role in reperfusion injury and that neutrophil
adherence and infiltration contribute significantly to coronary
endothelial dysfunction. Monocyte adhesion, if compounded
by enhancement of monocyte tissue factor expression due to
engagement of Mac-1 receptor, as reported by Fan and
Edgington (7) and Lo et al. (19), could add a local procoagu-
lant effect as well. Such a mechanism may explain the occa-
sional occurrence of persistent postinfarction ischemia despite
recanalization of occluded infarct-related artery or the slow
flow observed in the culprit artery (17).
The finding that activated neutrophils and monocytes man-
ifest increased density of Mac-1, whereas monocytes also
express significantly enhanced density of LFA-1 and their
ligand ICAM-1, suggests that after myocardial infarction,
leukocytes may adhere to each other and form microaggre-
gates. These may form locally at sites of adherence to dysfunc-
tional endothelium or in the vicinity of the infarct-related
coronary lesion and may embolize distally to small vessels,
causing microvascular plugging and impeding perfusion, as
depicted schematically in Figure 5. Engler et al. (20) actually
demonstrated, by histopathologic and electromicroscopic ex-
amination, leukocyte plugging in capillaries of ischemic myo-
cardium after reperfusion in a canine model, which lends
credence to this hypothesis.
In theory, the interruption of leukocyte–leukocyte and
leukocyte–endothelium interactions in acute myocardial infarc-
tion may be clinically salutary. Tanaka et al. (21) evaluated the
effect of anti-CD18 monoclonal antibody infusion on myocar-
dial neutrophil accumulation and infarct size in a dog model of
ischemia and reperfusion. They found that neutrophil accumu-
lation contributed to reduced postischemic microvascular per-
fusion, in keeping with the observation of Engler et al. (20);
however, anti-CD18 monoclonal antibody infusion did not
affect infarct size in that model. In rabbits, in contrast, it was
demonstrated that neutrophils do exacerbate tissue injury after
a 30-min period of ischemia (22). Infusion of an anti-CD18
monoclonal antibody before reperfusion resulted in a reduc-
tion of myocardial infarct size.
Acute myocardial infarction is a convenient model for the
study of changes in leukocyte adhesion molecule expression
secondary to ischemia and infarction because the magnitude of
the response is such that local coronary effects overflow into
the systemic circulation where they can be probed and quan-
titated by flow cytometry. Whether this represents saturation
of the trapping capacity of the coronary microcirculation or
some alteration of leukocyte adhesion molecules rendering
them nonfunctional yet still recognizable as an antigenic entity
by specific monoclonal antibodies cannot be presently deter-
mined. A similar process, although of a smaller extent and not
discernible systemically, may be operating in unstable angina
and non-Q wave myocardial infarction as well. Indeed, in-
creased expression of neutrophil and monocyte adhesion mol-
ecule Mac-1 across the coronary circulation, but not in the
systemic circulation, has been documented in patients with
unstable coronary artery disease (23). In contrast to the finding
in postmyocardial infarction patients, we have not recorded
similar changes measured in systemic blood in patients with
stable angina or in others admitted to the intensive care unit
for other indications. It is worthwhile to note with regard to the
specificity of this phenomenon that there have been a few
reports on changes in the expression of adhesion molecules in
the context of brain ischemia and infarction (24) and during
clinical cardiopulmonary bypass (25). Most of the studies
describing alterations of adhesion molecule expression in brain
pathology reported local changes by endothelial cells or on
infiltrating leukocytes. Nonetheless, one report (24) described
Figure 5. Schematic of possible interaction of activated monocytes
with each other or with neutrophils and with altered endothelium.
Enhanced expression of ICAM-1 as well as its beta2-integrin ligands
LFA-1 and Mac-1 on monocyte cell surface may facilitate their
attachment and give rise to aggregate formation. Similarly, monocytes
could adhere through the same pathway to altered endothelium that
expresses increased ICAM-1 concentration. Both mechanisms could
potentially result in microvascular obstruction.
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changes in beta2-integrin expression in circulating leukocytes
from patients with ischemic stroke. It is possible that similar
changes to those documented in the present study may be
encountered in other conditions involving tissue necrosis.
However, this is not a crucial point because all other patho-
logic processes can be easily differentiated from acute myocar-
dial infarction on the basis of clinical signs and symptoms, as
well as laboratory tests.
Conclusions. The present study confirms the hypothesis
that after acute myocardial infarction, circulating neutrophils
and monocytes display an increased cell surface concentration
of the adhesion molecules LFA-1 and Mac-1 and also mono-
cyte ICAM-1 and VLA-4, which indicate their activation with
respect to leukocyte endothelial adherence. This expression
signifies an enhanced propensity of leukocytes to adhere to
endothelium and provides the mechanism for endothelial
transmigration required for myocardial infiltration by leuko-
cytes, as documented after infarction. In addition, the signifi-
cantly increased expression of monocyte ICAM-1 points to a
possible role in leukocyte microaggregate formation through
association with its upregulated ligands LFA-1 and Mac-1 on
neutrophils and monocytes. Altered expression of leukocyte
adhesion molecules may be of clinical importance because it
provides a theoretical basis for changes in the coronary micro-
vascular bed during myocardial infarction. This mechanism
could serve as an explanation for the “no-reflow” phenomenon
or postinfarction sequelae as ongoing ischemia despite patency
of the culprit coronary artery. Because full elucidation of these
changes may yield novel therapeutic interventions, further
study in this field is warranted.
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